Breaking News Instant updates and real-time market news.

NKE

Nike

$84.55

0.3 (0.36%)

06:26
05/20/19
05/20
06:26
05/20/19
06:26

Nike adds new terms to contracts with athletes to support them during pregnancy

Nike is adding new terms to its contracts with athletes to better support them during pregnancy, the company announced on its website on Friday. The company stated: "Nike has supported thousands of female athletes for decades. We have learned and grown in how to best support our female athletes and have always worked to do our best to play a strong role in championing, celebrating and supporting female athletes and we are committed to continuing to do so. Last year we standardized our approach across all sports to support our female athletes during pregnancy, but we recognize we can go even further. Moving forward, our contracts for female athletes will include written terms that reinforce our policy. Our mission has always been to support athletes as they strive to be their best. We want to make it clear today that we support women as they decide how to be both great mothers and great athletes. We recognize we can do more and that there is an important opportunity for the sports industry to evolve to support female athletes." Reference Link

NKE Nike
$84.55

0.3 (0.36%)

04/10/19
SBSH
04/10/19
INITIATION
Target $100
SBSH
Buy
Nike assumed with a Buy rating, $100 price target at Citi
Citi analyst Paul Lejuez assumed coverage of Nike from Kate McShane and kept a Buy rating on the shares. He raised his price target for the stock to $100 from $96. Nike is the dominant player in the global athletic footwear and apparel market, which is a "healthy and growing market buoyed by structural tailwinds," Lejuez tells investors in a research note.
04/10/19
SBSH
04/10/19
DOWNGRADE
Target $68
SBSH
Neutral
Foot Locker assumed with a Neutral from Buy at Citi
Citi analyst Paul Lejuez assumed coverage of Foot Locker (FL) from Kate McShane and downgraded the shares to Neutral from Buy. He also lowered his price target for the stock to $68 from $72. While Foot Locker has "tailwinds at its back" in North America with comps inflecting positively in Q4, the company still faces many of the same headwinds as other specialty retailers given its "significant" mall exposure and EBIT pressure from direct-to-consumer, Lejuez tells investors in a research note. He believes Nike's direct-to-consumer ambitions are a "secular headwind" for Foot Locker.
04/12/19
JEFF
04/12/19
NO CHANGE
JEFF
Under Armour discounts flat to down for 12th straight month, says Jefferies
Jefferies analyst Randal Konik says his firm's March webscrapes illustrate that Under Armour's (UAA) percentage of product on discount is flat to down for the twelfth month in a row year-over-year, Jefferies analyst Randal Konik tells investors in a research note. Further, the webscrapes show Adidas's (ADDYY) percentage of product on discount is up for the twelfth month in a row year-over-year, adds the analyst. In addition, visits to Finish Line (FINL), Foot Locker (FL), and Under Armour websites reveal the HOVR, Project Rock, and Curry 6 are sold out in several sizes, indicating strong demand, says Konik. He believes Nike (NKE) continues to dominate Adidas in running in the U.S., with strength in Air VaporMax and Air Max 270. The analyst also thinks the data bodes well for Under Armour's's sales and margins in Q1.
04/18/19
PIPR
04/18/19
NO CHANGE
Target $30
PIPR
Overweight
Under Armour Q1 expectations 'at least achievable,' says Piper Jaffray
Piper Jaffray analyst Erinn Murphy says her work year-to-date indicates generally well controlled inventory across the domestic athletic industry. Currently, Under Armour (UAA) online clearance styles are down 19% year-over-year versus Nike's (NKE) down 5% and Adidas' (ADDYY) up 96%. The analyst believes industry competition "should remain rational" during 2019. Further, Q1 consensus expectations for Under Armour are "at least achievable" and management should maintain fiscal 2019 guidance, Murphy tells investors in a pre-earnings research note. The analyst this quarter has seen on-going traction with HOVR's footwear platform, broader focus with Under Armour's women's and a well-supported launch of Rush. She keeps an Overweight rating on Under Armour shares with a $30 price target.

TODAY'S FREE FLY STORIES

BAC

Bank of America

$27.93

-0.1 (-0.36%)

16:35
06/17/19
06/17
16:35
06/17/19
16:35
Upgrade
Bank of America rating change  »

Bank of America upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 06

    Aug

CYAD

Celyad

$13.50

-5.28 (-28.12%)

16:35
06/17/19
06/17
16:35
06/17/19
16:35
Hot Stocks
Celyad presents clinical update for CYAD-01 trials »

Celyad announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CINR

Ciner Resources

$18.87

-0.28 (-1.46%)

16:35
06/17/19
06/17
16:35
06/17/19
16:35
Hot Stocks
Ciner Resource Partners CEO Kirk Milling resigns »

On June 17, Ciner…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBAYF

Hudson's Bay

$0.00

(0.00%)

16:34
06/17/19
06/17
16:34
06/17/19
16:34
Hot Stocks
Hudson's Bay CFO to take medical leave of absence »

HBC announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARRY

Array BioPharma

$46.42

16.83 (56.88%)

16:34
06/17/19
06/17
16:34
06/17/19
16:34
Recommendations
Array BioPharma analyst commentary  »

Array BioPharma price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VNTR

Venator Materials

$4.93

-0.165 (-3.24%)

16:33
06/17/19
06/17
16:33
06/17/19
16:33
Hot Stocks
Venator Materials responds to Tronox answer, counterclaims »

Venator Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGI

MoneyGram

$1.44

-0.06 (-4.00%)

16:32
06/17/19
06/17
16:32
06/17/19
16:32
Hot Stocks
MoneyGram enters strategic partnership with Ripple »

MoneyGram announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

CAAP

Corporacion America Airport

$7.97

0.24 (3.10%)

16:32
06/17/19
06/17
16:32
06/17/19
16:32
Hot Stocks
Corporacion America Airport reports May traffic up 3.3% y/y »

Total passenger traffic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNV

Synovus

$32.71

-0.3 (-0.91%)

16:32
06/17/19
06/17
16:32
06/17/19
16:32
Hot Stocks
Synovus increases share repurchase authorization to $725M »

Synovus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

HCHC

HC2 Holdings

$2.51

0.06 (2.45%)

16:31
06/17/19
06/17
16:31
06/17/19
16:31
Hot Stocks
HC2 Holdings company American Natural Gas acquires ampCNG for $41M »

HC2 Holdings, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/17/19
06/17
16:30
06/17/19
16:30
Options
Preliminary option volume of 14.6M today »

Preliminary option volume…

SRNE

Sorrento Therapeutics

$3.63

0.49 (15.61%)

16:30
06/17/19
06/17
16:30
06/17/19
16:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
06/17/19
06/17
16:30
06/17/19
16:30
General news
Treasury capital data showed inflows of $46.9 B in long term U.S. assets in April »

Treasury capital data…

ASLN

Aslan Pharmaceuticals

$3.32

-0.23 (-6.48%)

16:27
06/17/19
06/17
16:27
06/17/19
16:27
Syndicate
Aslan Pharmaceuticals files to sell $17.34M of ADSs »

ASLAN Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SQ

Square

$72.22

0.65 (0.91%)

16:25
06/17/19
06/17
16:25
06/17/19
16:25
Hot Stocks
Square dismisses KPMG as auditor, engages Ernst & Young »

Square disclosed in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 27

    Jun

  • 01

    Aug

SNDK

Bought by WDC

$0.00

(0.00%)

, WDC

Western Digital

$36.26

-0.07 (-0.19%)

16:22
06/17/19
06/17
16:22
06/17/19
16:22
Hot Stocks
Nvidia names Donald Robertson as Chief Accounting Officer »

Nvidia (NVDA) announced…

SNDK

Bought by WDC

$0.00

(0.00%)

WDC

Western Digital

$36.26

-0.07 (-0.19%)

NVDA

Nvidia

$144.98

0.39 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 15

    Aug

CINR

Ciner Resources

$18.87

-0.28 (-1.46%)

16:22
06/17/19
06/17
16:22
06/17/19
16:22
Hot Stocks
Ciner Resources CEO Kirk Milling to resign »

Ciner Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACMR

ACM Research

$16.68

-0.57 (-3.30%)

16:22
06/17/19
06/17
16:22
06/17/19
16:22
Hot Stocks
ACM Research subsidiary executes agreements to prepare for STAR Market listing »

ACM Research announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 10

    Jul

LTXB

LegacyTexas Financial

$38.91

0.69 (1.81%)

16:22
06/17/19
06/17
16:22
06/17/19
16:22
Downgrade
LegacyTexas Financial rating change  »

LegacyTexas Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 26

    Aug

SQ

Square

$72.22

0.65 (0.91%)

16:21
06/17/19
06/17
16:21
06/17/19
16:21
Hot Stocks
Breaking Hot Stocks news story on Square »

Square dismisses KPMG as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 27

    Jun

  • 01

    Aug

PFE

Pfizer

$42.87

0.12 (0.28%)

, ARRY

Array BioPharma

$46.42

16.83 (56.88%)

16:21
06/17/19
06/17
16:21
06/17/19
16:21
On The Fly
Fly Intel: Wall Street's top stories for Monday »

Stocks drifted higher for…

PFE

Pfizer

$42.87

0.12 (0.28%)

ARRY

Array BioPharma

$46.42

16.83 (56.88%)

BID

Sotheby's

$56.13

20.735 (58.59%)

CJ

C&J Energy Services

$12.88

2.15 (20.05%)

FRAC

Keane Group

$7.49

0.495 (7.08%)

GM

General Motors

$36.13

0.47 (1.32%)

BA

Boeing

$354.90

7.71 (2.22%)

ARQL

ArQule

$9.56

1.39 (17.01%)

PAYS

Paysign

$11.32

-1.38 (-10.87%)

AHT

Ashford Hospitality

$3.50

-0.15 (-4.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 09

    Jul

  • 01

    Aug

  • 12

    Aug

  • 28

    Aug

  • 16

    Sep

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
06/17/19
06/17
16:20
06/17/19
16:20
Options
Closing CBOE SPX and VIX Index summary for June 17th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$15.85

0.05 (0.32%)

16:19
06/17/19
06/17
16:19
06/17/19
16:19
Hot Stocks
EQT Corporation sees Q2 sales volumes 'at high end of guidance range' »

EQT Corporation provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

EIGR

Eiger BioPharmaceuticals

$10.49

0.35 (3.45%)

16:18
06/17/19
06/17
16:18
06/17/19
16:18
Hot Stocks
Eiger BioPharmaceuticals: Breakthrough Therapy Designation granted for avexitide »

Eiger BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLT

Poly

$43.05

-1.61 (-3.61%)

16:17
06/17/19
06/17
16:17
06/17/19
16:17
Conference/Events
Poly participates in an investor webinar with Northland Capital Markets »

Northland Capital Markets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 28

    Jun

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.